ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00744562
Recruitment Status : Completed
First Posted : September 1, 2008
Last Update Posted : September 20, 2016
Sponsor:
Information provided by (Responsible Party):
OncoMed Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2011
  Actual Study Completion Date : January 2012